Pancreatic Cancer Research

ResearcherTokyo Metropolitan Komagome HospitalActive in the last 2 years

Naoto Egawa

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5110401507. Sources: OpenAlex.

Their work

Papers
15 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
61
Papers, trials and grants by year

2011: 2 papers · 2012: 1 paper · 2013: 2 papers · 2014: 1 paper · 2015: 3 papers · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 3 papers

Papers 15

  1. Plasma Protein Biomarkers for Early Detection of Pancreatic Cancer. Co-author DOI 10.1002/ijc.70637↗
  2. Circulating SDF4 as a potential diagnostic marker for early-stage pancreatic cancer Co-author DOI 10.1038/s41598-026-63925-x↗
  3. Associations Between Obesity, Diabetes Mellitus, and Pancreatic Cancer in the Japanese Population: A Mendelian Randomization Study. Co-author DOI 10.1111/cas.70344↗
  4. Genome-wide association meta-analysis identifies GP2 gene risk variants for pancreatic cancer. Co-author DOI 10.1038/s41467-020-16711-w↗
  5. Prediction model for pancreatic cancer risk in the general Japanese population. Co-author DOI 10.1371/journal.pone.0203386↗
  6. Associations between polymorphisms in folate-metabolizing genes and pancreatic cancer risk in Japanese subjects. Co-author DOI 10.1186/s12876-016-0503-7↗
  7. Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer. Co-author DOI 10.1038/bjc.2015.103↗
  8. Genome-wide association study-identified SNPs (rs3790844, rs3790843) in the NR5A2 gene and risk of pancreatic cancer in Japanese. Co-author DOI 10.1038/srep17018↗
  9. A Phase I Study of S-1 and Gemcitabine with Concurrent Radiotherapy in Patients with Non-Metastatic Advanced Pancreatic Cancer. Co-author PMID 26902051↗
  10. Lack of associations between genetic polymorphisms in GSTM1, GSTT1 and GSTP1 and pancreatic cancer risk: a multi-institutional case-control study in Japan. Co-author DOI 10.7314/apjcp.2014.15.1.391↗
  11. Association between variations in the fat mass and obesity-associated gene and pancreatic cancer risk: a case-control study in Japan. Co-author DOI 10.1186/1471-2407-13-337↗
  12. ABO blood type, long-standing diabetes, and the risk of pancreatic cancer. Co-author DOI 10.3748/wjg.v19.i16.2537↗
  13. Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinic… Co-author DOI 10.1007/s00280-012-1822-1↗
  14. An overview of genetic polymorphisms and pancreatic cancer risk in molecular epidemiologic studies. Co-author DOI 10.2188/jea.je20100090↗
  15. Incidence of and risk factors for developing pancreatic cancer in patients with chronic pancreatitis. Last author PMID 21661440↗

Closest collaborators

The 25 strongest of 61 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Makoto Ueno · 9 shared papers, 2011–2026 · strength 0.89
  2. Shogo Kikuchi · 9 shared papers, 2011–2026 · strength 0.89
  3. Masato Ozaka · 6 shared papers, 2012–2026 · strength 0.78
  4. Masahiro Nakatochi · 4 shared papers, 2018–2026 · strength 0.72
  5. Naoki Sasahira · 4 shared papers, 2018–2026 · strength 0.72
  6. Hiroshi Ishii · 10 shared papers, 2011–2026 · strength 0.70
  7. Yasushi Adachi · 3 shared papers, 2026 · strength 0.66
  8. Yingsong Lin · 8 shared papers, 2011–2026 · strength 0.65
  9. Itsuki Kageyama · 2 shared papers, 2026 · strength 0.48
  10. Asahi Hishida · 2 shared papers, 2026 · strength 0.48
  11. Satoshi Kobayashi · 3 shared papers, 2018–2026 · strength 0.48
  12. Keitaro Matsuo · 6 shared papers, 2013–2026 · strength 0.39
  13. Mitsuro Kanda · 1 shared paper, 2026 · strength 0.24
  14. Haruhisa Nakao · 6 shared papers, 2011–2018 · strength 0.23
  15. Takuji Okusaka · 2 shared papers, 2015–2026 · strength 0.22
  16. Shinichi Ohkawa · 5 shared papers, 2014–2018 · strength 0.20
  17. Atsushi Shimizu · 1 shared paper, 2026 · strength 0.18
  18. Yuriko N. Koyanagi · 1 shared paper, 2026 · strength 0.18
  19. Norie Sawada · 1 shared paper, 2026 · strength 0.18
  20. Sawako Kuruma · 4 shared papers, 2014–2018 · strength 0.17
  21. Kozue Nakamura · 4 shared papers, 2011–2016 · strength 0.13
  22. Mami Takahashi · 3 shared papers, 2014–2016 · strength 0.11
  23. Kazuaki Shimada · 3 shared papers, 2014–2016 · strength 0.11
  24. Masato Matsuyama · 3 shared papers, 2014–2016 · strength 0.11
  25. Manabu Morimoto · 2 shared papers, 2015–2018 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.